Arvinas (ARVN) FCF Margin (QoQ) (2018 - 2026)
Arvinas (ARVN) FCF Margin (QoQ) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Arvinas |
492.16 Mn |
-122.74 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-12,148.00 |
| Dec 31, 2025 |
-18,082.00 |
| Sep 30, 2025 |
29,130.00 |
| Jun 30, 2025 |
-38,545.00 |
| Mar 31, 2025 |
9,543.00 |
| Dec 31, 2024 |
-1,688.00 |
| Sep 30, 2024 |
-19,039.00 |
| Jun 30, 2024 |
45,008.00 |
| Mar 31, 2024 |
-57,169.00 |
| Dec 31, 2023 |
43,833.00 |
| Sep 30, 2023 |
-9,056.00 |
| Jun 30, 2023 |
12,253.00 |
| Mar 31, 2023 |
-9,617.00 |
| Dec 31, 2022 |
1,217.00 |
| Sep 30, 2022 |
3,373.00 |
| Jun 30, 2022 |
-1,788.00 |
| Mar 31, 2022 |
-9,446.00 |
| Dec 31, 2021 |
-746,440.00 |
| Sep 30, 2021 |
823,028.00 |
| Jun 30, 2021 |
-17,636.00 |
